Abstract
This case report describes the care of a 75-year-old gentleman with metastatic head and neck cancer who was highly symptomatic with intractable tenacious oropharyngeal secretions. The patient reported subjective benefit from oral atenolol. A literature review was undertaken and identified no previous studies on the use of β-blockers for secretions in malignant disease, although some anecdotal evidence for their use in motor neuron disease. The proposed underlying mechanism is that β1-blockade reduced the protein content of salivary secretions, hence reducing its viscosity. Further studies of both the role of β-adrenoreceptors in the control of secretion viscosity and the potential role of β-blockers in alleviating symptomatic tenacious secretions are warranted.
Subject
Medical–Surgical Nursing,Oncology (nursing),General Medicine,Medicine (miscellaneous)
Reference5 articles.
1. Management of sialorrhoea in motor neuron disease: a survey of current UK practice;Hobson;Amyotroph Lateral Scler Frontotemporal Degener,2013
2. The control of oral secretions in bulbar ALS/MND
3. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human unstimulated whole saliva flow rate and protein composition;Nederfors;Scand J Dent Res,1994
4. Beta-adrenergic receptors on human tracheal epithelial cells in primary culture;Davis;Am J Physiol,1990
5. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers;Westerlund;Eur J Clin Pharmacol,1985
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献